Literature DB >> 33446662

Acetylation-dependent glutamate receptor GluR signalosome formation for STAT3 activation in both transcriptional and metabolism regulation.

Xiang-Rong Li1, Xiaju Cheng1, Jia Sun2, Yan S Xu2, Nannan Chen1, Yimei Hao3, Chao Huang4, Y Eugene Chin5,6,7.   

Abstract

Besides their original regulating roles in the brain, spinal cord, retina, and peripheral nervous system for mediating fast excitatory synaptic transmission, glutamate receptors consisting of metabotropic glutamate receptors (GluRs) and ionotropic glutamate receptors (iGluRs) have emerged to have a critical role in the biology of cancer initiation, progression, and metastasis. However, the precise mechanism underpinning the signal transduction mediated by ligand-bound GluRs is not clearly elucidated. Here, we show that iGluRs, GluR1 and GluR2, are acetylated by acetyltransferase CREB-binding protein upon glutamate stimulation of cells, and are targeted by lysyl oxidase-like 2 for deacetylation. Acetylated GluR1/2 recruit β-arrestin1/2 and signal transducer and activator of transcription 3 (STAT3) to form a protein complex. Both β-arrestin1/2 and STAT3 are subsequently acetylated and activated. Simultaneously, activated STAT3 acetylated at lysine 685 translocates to mitochondria to upregulate energy metabolism-related gene transcription. Our results reveal that acetylation-dependent formation of GluR1/2-β-arrestin1/2-STAT3 signalosome is critical for glutamate-induced cell proliferation.

Entities:  

Year:  2021        PMID: 33446662     DOI: 10.1038/s41420-020-00389-6

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  48 in total

1.  Glutamate antagonists: deadly liaisons with cancer.

Authors:  E A Cavalheiro; J W Olney
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 2.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  N-methyl-D-aspartate receptor in human prostate cancer.

Authors:  M Abdul; N Hoosein
Journal:  J Membr Biol       Date:  2005-06       Impact factor: 1.843

Review 4.  The glutamatergic system outside the CNS and in cancer biology.

Authors:  Niki Kalariti; Nikos Pissimissis; Michael Koutsilieris
Journal:  Expert Opin Investig Drugs       Date:  2005-12       Impact factor: 6.206

Review 5.  Functions and mechanisms of non-histone protein acetylation.

Authors:  Takeo Narita; Brian T Weinert; Chunaram Choudhary
Journal:  Nat Rev Mol Cell Biol       Date:  2019-03       Impact factor: 94.444

Review 6.  The world of protein acetylation.

Authors:  Adrian Drazic; Line M Myklebust; Rasmus Ree; Thomas Arnesen
Journal:  Biochim Biophys Acta       Date:  2016-06-11

7.  Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma.

Authors:  So-Yeon Park; Seoung-Ae Lee; In-Hee Han; Byong-Chul Yoo; Seung-Hoon Lee; Jo-Yong Park; In-Ho Cha; Jin Kim; Sung-Weon Choi
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

8.  Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy.

Authors:  E Aronica; B Yankaya; G H Jansen; S Leenstra; C W van Veelen; J A Gorter; D Troost
Journal:  Neuropathol Appl Neurobiol       Date:  2001-06       Impact factor: 8.090

Review 9.  Glutamate signaling in peripheral tissues.

Authors:  Eiichi Hinoi; Takeshi Takarada; Taichi Ueshima; Yuriko Tsuchihashi; Yukio Yoneda
Journal:  Eur J Biochem       Date:  2004-01

10.  Quantitative hypermethylation of NMDAR2B in human gastric cancer.

Authors:  Jun-Wei Liu; Myoung Sook Kim; Jatin Nagpal; Keishi Yamashita; Luana Poeta; Xiaofei Chang; Juna Lee; Hannah Lui Park; Carmen Jeronimo; William H Westra; Masaki Mori; Chulso Moon; Barry Trink; David Sidransky
Journal:  Int J Cancer       Date:  2007-11-01       Impact factor: 7.396

View more
  3 in total

1.  Glutamate blunts cell-killing effects of neutrophils in tumor microenvironment.

Authors:  Tiantian Xiong; Ping He; Mi Zhou; Dan Zhong; Teng Yang; Wenhui He; Zhizhen Xu; Zongtao Chen; Yang-Wuyue Liu; Shuang-Shuang Dai
Journal:  Cancer Sci       Date:  2022-04-24       Impact factor: 6.518

Review 2.  Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect.

Authors:  Yu-Ling Bin; Hong-Sai Hu; Feng Tian; Zhen-Hua Wen; Mei-Feng Yang; Ben-Hua Wu; Li-Sheng Wang; Jun Yao; De-Feng Li
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

Review 3.  Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities.

Authors:  Meilan Hu; Fule He; Erik W Thompson; Kostya Ken Ostrikov; Xiaofeng Dai
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.